ROYAL BANK OF CANADA
BankPosition in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1000275
TORONTO, A6
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,968,601
+$1,124,091 QoQ
Shares Held
60,957
-0.6% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#130
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Derivatives in ARWR
reported options exposure · as of Mar 31, 2022CallValue
$0
CallShares
0
PutValue
$110,376
PutShares
2,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ARWR ranks #32 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in ARWR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,968,601 | 60,957 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,844,510 | 61,316 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,398,900 | 51,196 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,403,120 | 40,682 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,323,316 | 400,210 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $576,344 | 45,239 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $653,168 | 34,743 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $632,836 | 32,671 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $867,206 | 33,367 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $1,004,116 | 35,109 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $1,538,352 | 50,273 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $909,198 | 33,837 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,579,771 | 44,301 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $537,716 | 21,170 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,368,829 | 83,058 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,123,658 | 64,256 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,136,259 | 60,672 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $110,376 | 2,400 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $2,762,800 | 60,074 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,827,503 | 87,896 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,409,616 | 70,633 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,024,935 | 60,673 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,714,506 | 71,098 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $6,693,921 | 87,240 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,400,567 | 105,903 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,856,690 | 135,603 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,376,846 | 117,374 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||